NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Clinical trials for NEUROMYELITIS OPTICA SPECTRUM DISORDERS explained in plain language.
Never miss a new study
Get alerted when new NEUROMYELITIS OPTICA SPECTRUM DISORDERS trials appear
Sign up with your email to follow new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New treatment tested to tame rare, debilitating nerve disease
Disease control OngoingThis study is testing a drug called eculizumab in Chinese adults with a rare autoimmune disease called Neuromyelitis Optica Spectrum Disorder (NMOSD). The main goal is to see if the drug can reduce the frequency of disease attacks (relapses) and slow disability progression. Resea…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Massive brain scan project aims to revolutionize disease detection
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to create detailed reference charts of normal brain structure and function for the Chinese population by collecting brain scans from 10,000 healthy people and people with various brain conditions. Researchers will use these charts to help doctors make more accurat…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Sponsor: Beijing Tiantan Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC